Literature DB >> 12091260

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.

René Klysner1, Jesper Bent-Hansen, Hanne L Hansen, Marianne Lunde, Elisabeth Pleidrup, Dorte Loldrup Poulsen, Marc Andersen, Hans Erik Høpfner Petersen.   

Abstract

BACKGROUND: The highly recurrent nature of major depression in the young and the elderly warrants long-term antidepressant treatment. AIMS: To compare the prophylactic efficacy of citalopram and placebo in elderly patients; to evaluate long-term tolerability of citalopram.
METHOD: Out-patients, > or =65 years, with unipolar major depression (DSM-IV: 296.2 x or 296.3 x) and Montgomery-Asberg Depression Rating Scale score > or =22 were treated with citalopram 20-40 mg for 8 weeks. Responders continued on their final fixed dose of citalopram for 16 weeks before randomisation to double-blind treatment with citalopram or placebo for at least 48 weeks.
RESULTS: Nineteen of the 60 patients using citalopram v. 41 of the 61 patients using placebo had recurrence. Time to recurrence was significantly different between citalopram- and placebo-patients, in favour of citalopram (log-rank test, P<0.0001). Long-term treatment was well tolerated.
CONCLUSIONS: Long-term treatment with citalopram is effective in preventing recurrence of depression in the elderly and is well tolerated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091260     DOI: 10.1192/bjp.181.1.29

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

Review 1.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

2.  Antidepressants and unresponsive episodes in the elderly.

Authors:  James McGuinness; Mark Delicata
Journal:  BMJ Case Rep       Date:  2012-07-17

Review 3.  Major depressive disorder in older adults: benefits and hazards of prolonged treatment.

Authors:  Breno S Diniz; Charles F Reynolds
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

4.  Antidepressant prescribing patterns in the nursing home: second-generation issues revisited.

Authors:  Shruti Shah; Ben Schoenbachler; Joel Streim; Suzanne Meeks
Journal:  J Am Med Dir Assoc       Date:  2011-10-28       Impact factor: 4.669

Review 5.  Depression in adults: drug and physical treatments.

Authors:  Andrea Cipriani; Corrado Barbui; Rob Butler; Simon Hatcher; John Geddes
Journal:  BMJ Clin Evid       Date:  2011-05-25

Review 6.  Continuation treatment of major depressive disorder: is there a case for duloxetine?

Authors:  Trevor R Norman; James S Olver
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

Review 7.  Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age.

Authors:  Henry C Driscoll; Jordan F Karp; Mary Amanda Dew; Charles F Reynolds
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 8.  Depression in adults: drug and physical treatments.

Authors:  Corrado Barbui; Rob Butler; Andrea Cipriani; John Geddes; Simon Hatcher
Journal:  BMJ Clin Evid       Date:  2007-06-15

9.  Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.

Authors:  Anthony J Rothschild; Boadie W Dunlop; David L Dunner; Edward S Friedman; Alan Gelenberg; Peter Holland; James H Kocsis; Susan G Kornstein; Richard Shelton; Madhukar H Trivedi; John M Zajecka; Corey Goldstein; Michael E Thase; Ron Pedersen; Martin B Keller
Journal:  Psychopharmacol Bull       Date:  2009

10.  Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression.

Authors:  Yuhua Bao; Edward P Post; Thomas R Ten; Bruce R Schackman; Martha L Bruce
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.